Correction to: Synthesis, Characterization and Antimicrobial Activity of Bis(Phthalimido)Piperazine and its Derivatives: a New Class of Bioactive Molecules with Enhanced Safety and Efficacy
暂无分享,去创建一个
[1] M. S. Mostafa,et al. Synthesis and Antimicrobial Activities of Some New Heterocyclic Compounds Based on 6-Chloropyridazine-3(2H)-thione , 2013 .
[2] R. Kharb,et al. New insights into chemistry and anti-infective potential of triazole scaffold. , 2011, Current medicinal chemistry.
[3] M. Másson,et al. Antimicrobial activity of piperazine derivatives of chitosan , 2008 .
[4] Ashok Kumar,et al. Synthesis and antimicrobial evaluation of new chalcones containing piperazine or 2,5-dichlorothiophene moiety. , 2007, Bioorganic & medicinal chemistry letters.
[5] M. Drew,et al. Coordination and extraction studies of an unexplored bi-functional ligand, carbamoyl methyl pyrazole (CMPz) with uranium(VI), lanthanum(III) and cerium(III) nitrates , 2007 .
[6] C. Kavitha,et al. Synthesis and in vitro antimicrobial studies of medicinally important novel N-alkyl and N-sulfonyl derivatives of 1-[bis(4-fluorophenyl)-methyl]piperazine. , 2006, Bioorganic & medicinal chemistry.
[7] Ramesh Chandra,et al. Synthesis and antimicrobial activity of N-alkyl and N-aryl piperazine derivatives. , 2006, Bioorganic & medicinal chemistry.
[8] A. Foroumadi,et al. Synthesis and in vitro antibacterial activity of some N-(5-aryl-1,3,4-thiadiazole-2-yl)piperazinyl quinolone derivatives. , 2003, Farmaco.
[9] C. Walsh. Opinion — anti-infectives: Where will new antibiotics come from? , 2003, Nature Reviews Microbiology.
[10] G. Kaatz,et al. Piperazinyl-linked fluoroquinolone dimers possessing potent antibacterial activity against drug-resistant strains of Staphylococcus aureus. , 2003, Bioorganic & medicinal chemistry letters.
[11] C. Walsh. Antibiotics: Actions, Origins, Resistance , 2003 .
[12] He Zhao,et al. Indoline and piperazine containing derivatives as a novel class of mixed D(2)/D(4) receptor antagonists. Part 2: asymmetric synthesis and biological evaluation. , 2002, Bioorganic & medicinal chemistry letters.
[13] M. Kimura,et al. Novel diphenylalkyl piperazine derivatives with dual calcium antagonistic and antioxidative activities. , 2002, Bioorganic & medicinal chemistry letters.
[14] E A Emini,et al. Identification of MK-944a: a second clinical candidate from the hydroxylaminepentanamide isostere series of HIV protease inhibitors. , 2000, Journal of medicinal chemistry.
[15] S M Teutsch,et al. Trends in infectious diseases mortality in the United States. , 1996, JAMA.
[16] T. Gootz. Discovery and development of new antimicrobial agents , 1990, Clinical Microbiology Reviews.
[17] M. Finland. New developments in antibiotics. Future clinical studies for the National Institute of Allergy and Infectious Diseases. , 1978, Annals of internal medicine.
[18] R. Weis,et al. New N-methylpiperazinyl derivatives of bicyclic antiprotozoal compounds. , 2012, European journal of medicinal chemistry.
[19] Alan R. Katritzky,et al. Handbook of heterocyclic chemistry , 1985 .